Resmiterom Efficacy & Safety in Patients With MASH

Clinical trial NCT07249788 · RECRUITING

Trial details

NCT number: NCT07249788
Sponsor: Nabiqasim Industries (Pvt) Ltd
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

MASH - Metabolic Dysfunction-Associated Steatohepatitis

Start date: 2025-10-17
Primary completion: 2026-10-16
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.